(S (S (VP (VBG Predicting) (SBAR (IN whether) (S (NP (DT a) (NN chemical) (NN structure)) (VP (NNS shares) (NP (DT a) (JJ desired) (JJ biological) (NN effect))))))) (VP (MD can) (VP (VB have) (NP (NP (DT a) (JJ significant) (NN impact)) (PP (IN for) (NP (NP (JJ in-silico) (NN compound) (NN screening)) (PP (IN in) (NP (JJ early) (NN drug) (NN discovery)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD developed) (NP (NP (DT a) (JJ deep) (NN learning) (NN model)) (SBAR (WHADVP (WRB where)) (S (NP (NN compound) (NNS structures)) (VP (VBP are) (VP (VP (VBN represented) (PP (IN as) (NP (NN graphs)))) (CC and) (VP (ADVP (RB then)) (VBD linked) (PP (TO to) (NP (PRP$ their) (JJ biological) (NN footprint)))))))))) (. .))
(S (S (VP (TO To) (VP (VB make) (S (NP (DT this) (JJ complex) (NN problem)) (ADJP (RB computationally) (JJ tractable)))))) (, ,) (NP (JJ compound) (NNS differences)) (VP (VBD were) (VP (VBN mapped) (PP (TO to) (NP (JJ biological) (NN effect) (NNS alterations))) (S (VP (VBG using) (NP (JJ Siamese) (NNP Graph) (NNP Convolutional) (NNP Neural) (NNP Networks)))))) (. .))
(S (NP (DT The) (VBN proposed) (NN model)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VP (VB learn) (NP (JJ new) (NNS representations)) (PP (IN from) (NP (NN chemical) (NNS structures)))) (CC and) (VP (VB identify) (NP (NP (ADJP (RB structurally) (JJ dissimilar)) (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (JJ similar) (JJ biological) (NNS processes)) (PP (IN with) (NP (JJ high) (NN precision))))))))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (PP (IN by) (S (VP (VBG utilizing) (NP (JJ deep) (NNS ensembles)) (S (VP (TO to) (VP (VB estimate) (NP (NN uncertainty)))))))) (, ,) (NP (PRP we)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB provide) (NP (NP (ADJP (JJ reliable) (CC and) (JJ accurate)) (NNS predictions)) (PP (IN for) (NP (NP (NN chemical) (NNS structures)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (RB very) (JJ different) (PP (IN from) (NP (NP (DT the) (NNS ones)) (VP (VBN used) (PP (IN during) (NP (NN training)))))))))))))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (JJ novel) (NN inference) (NN approach)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (JJ trained) (NNS models)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB estimate) (NP (NP (DT the) (NN signaling) (NNS pathways)) (VP (VBN affected) (PP (IN by) (NP (DT a) (NN compound) (NN perturbation))) (PP (IN in) (NP (DT a) (JJ specific) (NN cell) (NN line))))) (, ,) (S (VP (VBG using) (NP (RB only) (PRP$ its) (NN chemical) (NN structure)) (PP (IN as) (NP (NN input)))))))))))))) (. .))
(S (PP (IN As) (NP (DT a) (NN use) (NN case))) (, ,) (NP (DT this) (NN approach)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB infer) (NP (NP (VBG signaling) (NNS pathways)) (VP (VBN affected) (PP (IN by) (NP (NNP FDA-approved) (NN anticancer) (NNS drugs)))))))))) (. .))
